Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

(2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride

(2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride is listed in the pharmaceutical impurity collection under CAS 88046-01-9. Its represented structure has formula C6H12Cl2N6S2 and a calculated molecular weight of 303.24 g/mol.

2D chemical structure

H C l H C l N H H 2 N N H N S N H N H 2 S

Chemical identity

Catalog name
(2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride
Common name
Not available
Chemical name
(2-carbamimidamido-1,3-thiazol-4-yl)methyl carbamimidothioate;dihydrochloride
CAS
88046-01-9
SMILES
Cl.Cl.N=C(N)Nc1nc(CSC(=N)N)cs1
InChI
InChI=1S/C6H10N6S2.2ClH/c7-4(8)12-6-11-3(2-14-6)1-13-5(9)10;;/h2H,1H2,(H3,9,10)(H4,7,8,11,12);2*1H
InChIKey
FTKAAVQOOXXUGW-UHFFFAOYSA-N

Record ID: A04cfe4fb212d

Computed properties

C6H12Cl2N6S2 Molecular formula
303.244 g/molMolecular weight
301.9942 DaMonoisotopic exact mass
124.66 ŲTopological polar surface area
1.4187 Calculated LogP (Wildman–Crippen)
75.3559 cm³/molMolar refractivity (Wildman–Crippen)
5 countHydrogen-bond acceptors
5 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. The SMILES contains 3 disconnected components. Calculations retain all represented components.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N S 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight303.24445.19
Calculated LogP (Wildman–Crippen)1.418732.19
Topological polar surface area124.6683.23
Hydrogen-bond acceptors565.12
Hydrogen-bond donors594.13
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC6H12Cl2N6S2dimensionless
Molecular weight303.244g/mol
Monoisotopic exact mass301.9942Da
Topological polar surface area124.66Ų
Calculated LogP (Wildman–Crippen)1.4187dimensionless
Molar refractivity (Wildman–Crippen)75.3559cm³/mol
Hydrogen-bond acceptors5count
Hydrogen-bond donors5count
Rotatable bonds (strict)3count
Heavy atoms16count
Heteroatoms10count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.1667fraction
Formal charge0e
Disconnected components3count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area113.4159Ų
Valence electrons92count
Radical electrons0count
Bertz complexity354.5429index
Balaban J0index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride

Qualification and safety assessment of (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride

Explore toxicological qualification of (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride and ICH M7 mutagenic impurity assessment of (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride and acceptable intake and limit justification for (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for (2-[(Diaminomethylidene)amino]thiazol-4-yl)methyl Carbamimidothioate Dihydrochloride

Explore Altox services and software through the Altox Pharma-Hub.